Journal of the American College of Surgeons
Volume 201, Issue 3 , Pages 412-417 , September 2005

Transfusion Free Surgery: Single Institution Experience of 27 Consecutive Liver Transplants in Jehovah’s Witnesses

Received 3 February 2005 ,Revised 18 March 2005 ,Accepted 7 April 2005.

References 

  1. Wiesner RH , McDiarmid SV , Kamath PS , et al.   MELD and PELD (application of survival models to liver allocation) . Liver Transpl . 2001;7:567–580
  2. Schroeder RA , Johnson LB , Plotkin JS , et al.   Total blood transfusion and mortality after orthotopic liver transplantation . Anesthesiology . 1999;91:329–330
  3. Ceccherini-Nelli L , Filipponi F , Mosca F , Campa M . The risk of contracting an infectious disease from blood transfusion . Transpl Proc . 2004;36:680–682
  4. Hillyer CD , Josephson CD , Blajchman MA , et al.   Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine . Hematology . 2003;575–589
  5. Shander A . Emerging risks and outcomes of blood transfusion in surgery . Semin Hematol . 2004;41(1 Suppl 1):117–124
  6. Goodnough LT , Price TH , Rudnick S , et al.   Preoperative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy . Transfusion . 1992;32:441–445
  7. Jabbour N , Gagandeep S , Mateo R , et al.   Live donor liver transplantation without blood products (Strategies developed for Jehovah’s Witnesses offer broad application) . Ann Surg . 2004;240:350–357
  8. Matot I , Scheininit O , Jurim O , Eid A . Effectiveness of acute normovolemic hemodilution to minimize allogeneic blood transfusion in major liver resections . Anesthesiology . 2002;97:794–800
  9. Spain DA , Miller FB , Bergamini TM , et al.   Quality assessment of intraoperative blood salvage and autotransfusion . Am Surg . 1997;63:1059–1063
  10. Viana JS , Pereira MG , Lozano L , et al.   Thrombelastographic evidence of hyperfibrinolysis during liver transplantation for familial amyloidotic polyneuropathy ATTR met 30 . Transpl Proc . 2000;32:2645–2646
  11. Jabbour N , Singh G , Cheng A , et al.   Recombinant human coagulation factor VIIa in Jehovah’s Witness patients undergoing liver transplantation . Am Surg . 2005;2:175–179
  12. Spence RK . The cost of transfusion and alternatives . Surgery . 2002;131:236–237
  13. Pereira A , Sanz C . A model of the health and economic impact of posttransfusion hepatitis C (application to cost-effectiveness analysis of further expansion of HCV screening protocols) . Transfusion . 2000;40:1182–1191
  14. Crémieux P , Barrett B , Anderson K , Slavin MB . Cost of outpatient blood transfusion in cancer patients . J Clin Oncol . 2000;18:2755–2761
  15. The National Blood Data Resource Center. Available at http://www.nbdrc.org. Accessed May 17, 2005.
  16. Llewelyn CA , Hewitt PE , Knight RS , et al.   Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion . Lancet . 2004;363:417–421
  17. Iwamoto M , Jernigan DB , Guasch A , et al.   West Nile Virus in Transplant Recipients Investigation Team. Transmission of West Nile virus from an organ donor to four transplant recipients . N Engl J Med . 2003;348:2196–2203

 Competing Interests Declared: None.

PII: S1072-7515(05)00403-5

doi: 10.1016/j.jamcollsurg.2005.04.006

Journal of the American College of Surgeons
Volume 201, Issue 3 , Pages 412-417 , September 2005